Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Downing

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of Laboratory and Clinical Medicine|June 1, 1980
The interaction of proteases, antithrombin III, and heparinM R Downing
Analytical Biochemistry|August 1, 1976
High-pressure liquid chromatographic analysis of amino acid phenylthiohydantoins: comparison with other techniquesM R Downing, K G Mann
Biochimica Et Biophysica Acta|October 6, 1980
Physical, chemical, and immunochemical studies of apolipoprotein A-I from pigeon plasma high density lipoproteinsS J Mao, M R Downing, B A Kottke
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Human prothrombin activation productsM R Downing, R J Butkowski, K G Mann
Biochemistry|June 27, 1978
Comparison of the inhibition of thrombin by three plasma protease inhibitorsM R Downing, J W Bloom, K G Mann
The Journal of Biological Chemistry|July 25, 1977
Primary structure of human prethrombin 2 and alpha-thrombinR J Butkowski, J Elion, M R Downing, et al.
Bibliotheca Haematologica|January 1, 1977
Thrombin: structural features related to specificityM R Downing, J Elion, R J Butkowski, et al.
The Journal of Biological Chemistry|December 10, 1975
Human prothrombin activationM R Downing, R J Butkowski, M M Clark, et al.
Behring Institute Mitteilungen|August 1, 1988
The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress reportW Adamson, J C Egrie, J K Browne, et al.
Contributions to Nephrology|January 1, 1989
USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patientsJ W Eschbach, M R Downing, J C Egrie, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Laboratory and Clinical Medicine|June 1, 1980
The interaction of proteases, antithrombin III, and heparinM R Downing
Analytical Biochemistry|August 1, 1976
High-pressure liquid chromatographic analysis of amino acid phenylthiohydantoins: comparison with other techniquesM R Downing, K G Mann
Biochimica Et Biophysica Acta|October 6, 1980
Physical, chemical, and immunochemical studies of apolipoprotein A-I from pigeon plasma high density lipoproteinsS J Mao, M R Downing, B A Kottke
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Human prothrombin activation productsM R Downing, R J Butkowski, K G Mann
Biochemistry|June 27, 1978
Comparison of the inhibition of thrombin by three plasma protease inhibitorsM R Downing, J W Bloom, K G Mann
The Journal of Biological Chemistry|July 25, 1977
Primary structure of human prethrombin 2 and alpha-thrombinR J Butkowski, J Elion, M R Downing, et al.
Bibliotheca Haematologica|January 1, 1977
Thrombin: structural features related to specificityM R Downing, J Elion, R J Butkowski, et al.
The Journal of Biological Chemistry|December 10, 1975
Human prothrombin activationM R Downing, R J Butkowski, M M Clark, et al.
Behring Institute Mitteilungen|August 1, 1988
The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress reportW Adamson, J C Egrie, J K Browne, et al.
Contributions to Nephrology|January 1, 1989
USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patientsJ W Eschbach, M R Downing, J C Egrie, et al.
Pageof 2